Email Alert RSS
Volume 14 Issue 5
Sep.  2023
Turn off MathJax
Article Contents
Abstract
References
Related Articles
WU Yun, CHEN Jiawei, WANG Tong, LI Jin, ZHANG Ge, KANG Wei, ZHANG Jingjia, SUN Hongli, XU Yingchun, LIU Yali. In Vitro Activity of Sixteen Drugs Against Staphylococcus Aureus, Enterococcus Faecalis and Enterococcus Faecium: A Multicentre Cross-sectional Study in China[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 999-1004. DOI: 10.12290/xhyxzz.2023-0070
Citation: WU Yun, CHEN Jiawei, WANG Tong, LI Jin, ZHANG Ge, KANG Wei, ZHANG Jingjia, SUN Hongli, XU Yingchun, LIU Yali. In Vitro Activity of Sixteen Drugs Against Staphylococcus Aureus, Enterococcus Faecalis and Enterococcus Faecium: A Multicentre Cross-sectional Study in China[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 999-1004. DOI: 10.12290/xhyxzz.2023-0070
shu

In Vitro Activity of Sixteen Drugs Against Staphylococcus Aureus, Enterococcus Faecalis and Enterococcus Faecium: A Multicentre Cross-sectional Study in China

  • 1.

    Department of Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • 2.

    Graduate School, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds: 

Special Foundation for National Science and Technology Basic Research Program of China: Establishment of A Standardised Stratified Surveillance System for Infectious Pathogens and Investigation of Drug Susceptibility and Resistance in China 2019FY101200

More Information
  • Corresponding author:

    XU Yingchun, E-mail: xycpumch@139.com

    LIU Yali, E-mail: liuyluijk@163.com

  • Received Date: February 09, 2023
  • Accepted Date: May 08, 2023
  • Available Online: May 10, 2023
  • Issue Publish Date: September 29, 2023
    Graphical Abstract
    • Abstract
  •   Objective  To evaluate the in vitro antimicrobial activities of 16 common agents against Staphylococcus aureus, Enterococcus faecium and Enterococcus faecalis to provide data for the rational clinical use of drugs.
      Methods  From 1st January to 31st December in 2019, Staphylococcus aureus, Enterococcus faecium and Enterococcus faecalis were collected from 24 hospitals in 18 provinces in China. Antimicrobial susceptibility testing was conducted by automated instrumentation method, and WHONET 5.6 software was used to calculate the drug sensitivity results of the strains to 16 antibacterial drugs including vancomycin, norvancomycin, fusidic acid and linezolid.
      Results  A total of 255 strains of Staphylococcus aureus, 117 strains of Enterococcus faecalis and 114 strains of Enterococcus faecium were collected. Blood was the most common specimen type (22.2%, 108/486), followed by urine (18.9%, 82/486). According to the drug sensitivity results, vancomycin, norvancomycin, linezolid and teicoplanin maintained high activity to all strains. All Staphylococcus aureus and Enterococcus faecalis were sensitive to vancomycin and teicoplanin, while the resistance rates of vancomycin and teicoplanin against Enterococcus faecium were 4.4% and 2.6%, respectively. The resistance rates of linezolid against Staphylococcus aureus, Eenterococcus faecium and Eenterococcus fascalis were 0, 0 and 4.3%, respectively. Norvancomycin and vancomycin showed similar antibacterial activity against Staphylococcus aureus, Enterococcus faecium, and Enterococcus faecalis, with 50% minimum inhibitory concentration (MIC50) of 1 mg/L, and MIC90 of 2 mg/L. The isolation rate of methicillin-resistant Staphylococcus aureas(MRSA) was 35.7%, with 13.2% resistance to fusidic acid and 3.0% in methicillin-susceptible Staphylococcus aureas.
      Conclusions  The activity of the 16 antimicro-bial drugs against Staphylococcus aureus, Enterococcus faecium and Enterococcus faecalis varied considerably. The data will provide reference for the rational use of antimicrobial drugs.
    • FullText(HTML)
    • References (15)
  • [1]
    Pendleton JN, Gorman SP, Gilmore BF. Clinical relevance of the ESKAPE pathogens[J]. Expert Rev Anti Infect Ther, 2013, 11: 297-308. DOI: 10.1586/eri.13.12
    [2]
    Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. 33rd ed. CLSI document M100. Wayne, PA: CLSI, 2023.
    [3]
    European Committee on Antimicrobial Susceptibility Testing. EUCAST clinical breakpoint table [EB/OL]. [2023-02-10]. https://www.eucast.org/clinical_breakpoints/.
    [4]
    Arias CA, Murray BE. Emergence and management of drug-resistant enterococcal infections[J]. Expert Rev Anti Infect Ther, 2008, 6: 637-55. DOI: 10.1586/14787210.6.5.637
    [5]
    CHINET中国细菌耐药监测网.CHINET中国细菌耐药检测结果(2022年1—12月)[EB/OL ].(2022-09)[2023-07-03]. https://max.book118.com/html/2022/0913/6213051034004235.shtm.
    [6]
    Ding L, Yang Y, Zheng C, et al. Activities of Eravacycline, Tedizolid, Norvancomycin, Nemonoxacin, Ceftaroline, and Comparators against 1, 871 Staphylococcus and 1, 068 Enterococcus Species Isolates from China: Updated Report of the CHINET Study 2019 [J]. Microbiol Spectr, 2022, 10: e0171522. DOI: 10.1128/spectrum.01715-22
    [7]
    Shariati A, Dadashi M, Chegini Z, et al. The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopri-stin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis. Antimicrob Resist Infect Control [J]. Antimicrob Resist Infect Control, 2020, 9: 56.
    [8]
    Schöfer H, Simonsen L. Fusidic acid in dermatology: an updated review [J]. Eur J Dermatol, 2010, 20: 6-15. DOI: 10.1684/ejd.2010.0833
    [9]
    Goudarzi M, Seyedjavadi S, Bagheri P, et al. Prevalence and genetic characteristics of fusidic acid resistant Staphylococcus aureus clinical isolates: Emergence of t030 strains carrying fusB in Tehran, Iran [J]. Acta Microbiol Immunol Hung, 2023, 70: 126-133. DOI: 10.1556/030.2023.01997
    [10]
    Zhanel GG, Adam HJ, Baxter M, et al. In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18) [J]. J Antimicrob Chemother, 2021, 76: 1808-1814. DOI: 10.1093/jac/dkab098
    [11]
    Chen S, Rao L, Lin C. The Dissemination of Fusidic Acid Resistance Among Staphylococcus epidermidis Clinical Isolates in Wenzhou, China [J]. Infect Drug Resist, 2022, 15: 2537-2544. DOI: 10.2147/IDR.S365071
    [12]
    Liu X, Deng S, Huang J, et al. Dissemination of macrolides, fusidic acid and mupirocin resistance among Staphylococcus aureus clinical isolates [J]. Oncotarget, 2017, 8: 58086-58097.
    [13]
    胡付品, 郭燕, 朱德妹, 等. 2018年CHINET中国细菌耐药性监测[J]. 中国感染与化疗杂志, 2020, 20: 1-10. https://www.cnki.com.cn/Article/CJFDTOTAL-KGHL202001001.htm
    [14]
    胡付品, 郭燕, 朱德妹, 等. 2020年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志, 2021, 21: 377-387. https://www.cnki.com.cn/Article/CJFDTOTAL-KGHL202205001.htm
    [15]
    郑永贵, 胡付品, 朱德妹, 等. 2019年CHINET细菌耐药监测网二级医院监测结果[J]. 中国感染与化疗杂志, 2020, 20: 585-593. https://www.cnki.com.cn/Article/CJFDTOTAL-KGHL202006001.htm
    • Related Articles

  • Related Articles

    [1]ZHANG Shan, LIU Jie. Interpretation of NCCN Clinical Practice Guidelines for Primary Cutaneous Lymphomas (Version 1.2024) Based on the Current Diagnosis and Treatment Status of China[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1029-1037. DOI: 10.12290/xhyxzz.2024-0605
    [2]YAN Xinchun, HUO Li. Evaluation of Von Hippel-Lindau Syndrome Through Novel Small Molecular Tracer 68Ga-NY104 PET/CT Imaging[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 911-915. DOI: 10.12290/xhyxzz.2024-0216
    [3]ZHANG Ning, YANG Chenhao, ZHOU Liangrui, SUN Xiaohong, LIU Xiaohong, KANG Lin, LI Ji, LI Hailong. Cronkhite-Canada Syndrome Combined with Asymptomatic Novel Coronavirus Infection: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(2): 406-412. DOI: 10.12290/xhyxzz.2023-0476
    [4]LIU Yuan, ZHAO Lin. Update and Interpretation of 2022 National Comprehensive Cancer Network Clinical Practice Guidelines for Gastric Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 999-1004. DOI: 10.12290/xhyxzz.2022-0271
    [7]Ming-sheng MA, Xü-de ZHANG, Min WEI, Shi-min ZHAO, Zheng-qing QIU. Efficacy of Low Dose Corticosteroid Therapy in Duchenne Muscular Dystrophy[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(4): 384-388. DOI: 10.3969/j.issn.1674-9081.2014.04.006
    [9]Jie LIU, Yue-ping ZENG, Chun-xia HE, Qin LONG, Hong-zhong JIN, Qiu-ning SUN. Corticosteroids plus Intravenous Immunoglobulin in the Treatment of 7 Cases with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(4): 381-385. DOI: 10.3969/j.issn.1674-9081.2012.04.004
    [10]Shuai TANG, Jie YI, Yu-guang HUANG. Cardiovascular Responses of Intubation with Shikani Seeing Optical Stylet and Macintosh Laryngoscope[J]. Medical Journal of Peking Union Medical College Hospital, 2012, 3(3): 314-317. DOI: 10.3969/j.issn.1674-9081.2012.03.015

  • Cited by

    Periodical cited type(2)

    1. 刘洪港，张筱，赵杰，石艳红，王振，李玉峰，汪建华. 山东鸭源粪肠球菌的分离鉴定及药物敏感性分析. 家禽科学. 2025(02): 26-31+125 .
    2. 季欧，仲瑞雪，刘小莉，陈韵蓓，郎志刚，段小云. 骨折内固定术后感染金黄色葡萄球菌患者的耐药监测及临床分析. 中国医药. 2024(04): 571-575 .

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1636) PDF downloads (91) Cited by(2)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close